Young-Jin Kim, Paean, Inc. and other investors entered into an agreement to acquire 50% stake in Handok Pharmaceuticals Co., Ltd. (KOSE:A002390) from Hoechst GmbH on September 26, 2012. Young-Jin Kim will acquire 0.696 million shares representing 6% stake in Handok Pharmaceuticals Co., Ltd. as a result of which his stake increases to 14.12%. Paean, Inc. will acquire approximately 3.48 million shares representing 29.99% stake in Handok Pharmaceuticals.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,700 KRW | +8.73% | +7.69% | +2.80% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+2.80% | 137M | |
+37.74% | 723B | |
+32.22% | 598B | |
-2.07% | 364B | |
+20.25% | 331B | |
+2.99% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+7.43% | 169B |
- Stock Market
- Equities
- A002390 Stock
- News HANDOK Inc.
- Young-Jin Kim, Paean, Inc. and other investors entered into an agreement to acquire 50% stake in Handok Pharmaceuticals Co., Ltd. from Hoechst GmbH.